For example, in a mouse model of prostate cancer, Tp53 loss resulted in enhanced transcription of cytokines and chemokines, accumulation of ROS and protein oxidation products, enhanced macrophage activation and neutrophil clearance, hypersensitivity to LPS, and high expression of metabolic markers (Komarova et al., 2005). Here, TP53 is linked to prostate carcinoma.